A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer

Author(s): Arun Singh Lalotra, Vishesh Singh, Bharat Khurana, Shelly Agrawal, Shubham Shrestha, Daisy Arora*

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 44 , 2020

Become EABM
Become Reviewer
Call for Editor


Background: Skin is the largest organ of the body and helps to regulate several physiological functions. It acts as a barrier that protects the body against UV-radiation, toxic substances, infections, etc. The abnormal growth of the skin cells is called skin cancer. Different types of skin cancer can be classified as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC); which mainly occur due to chronic exposure to UV- sunlight and pollution.

Methods: The conventional topical treatments of skin cancer such as cream, gel, ointment, etc., are more occlusive and thus they do not penetrate deep into the skin (dermal layer) and remain at the upper part of the skin (epidermal layer). The stratum corneum acts as a physiological barrier for the drug-loaded in the conventional formulation. The novel carrier systems have the potential to facilitate the penetration of the drug deep into the skin (dermal layer) because these have less size and higher flexibility than conventional treatment.

Conclusion: In the present review, we have discussed various novel carrier systems being investigated for the topical application of chemotherapeutic agents for efficient skin targeting and better dermatological as well as therapeutic benefits with minimal systemic exposure and toxicity.

Keywords: Skin cancer, oxidative stress, UV-B radiation, nanocarriers, topical vesicular systems, ethosomes, transethosomes.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 19 August, 2020
Page: [5720 - 5731]
Pages: 12
DOI: 10.2174/1381612826666200819202821
Price: $65

Article Metrics

PDF: 32